A clinical trial of laser acupuncture treatment for breast cancer related lymphedema

The mechanism of laser acupuncture in promoting the vascular endothelial growth factor-C (VEGF-C) and vascular endothelial growth factor-D(VEGF-D) for breast cancer-related lymphedema (BCRL)

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-ICR-14005703

Enrollment

Unknown

Registered

2014-06-02

Start date

2014-10-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer related lymphedema

Interventions

Treating Group:Laser Acupuncture

waiting group:none

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Women aged above 18 years with unilateral lymphedema,resulting from surgery and/or radiation therapy and/or chemotherapy for breast cancer; a clinical diagnosis of breast cancer,stage I, II and III, referring to 2003 WHO diagnostic criteria for classification.

Exclusion criteria

Exclusion criteria: Women with severe lymphedema,defined as 8 cm in circumference difference between affected and unaffected arms; upper extremity edema caused by subclavian/axillary vein thrombosis or stenosis by ultrasound examination; tumor metastasis, cellulitis, venous thrombosis, chronic inflammatory disease or a history of severe trauma; received radiation therapy within six months; a history of photosensitivity and can not accept laser treatment; participated in other clinical trials within past three months;pregnancy or prepare to pregnant.

Design outcomes

Primary

Measure	Time frame
upper -limb circumference;	—

Countries

China

Contacts

Public ContactWang Lizhen

rain_liz_wang@hotmaill.com+86 13817280004

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026